FitLife Brands (FTLF) Q2 2026 earnings review
Irwin Drives Top-Line Surge, But Legacy Brands Keep Bleeding
FitLife Brands reported a 65% YoY revenue surge to $26.5 million, entirely manufactured by the August 2025 acquisition of Irwin Naturals. Net income rose a modest 12% to $2.0 million as lower margins from the acquired business compressed profitability. The story here is a tale of two companies: Irwin is accelerating, driving a successful online turnaround approaching an $11 million run rate on Amazon. Conversely, Legacy FitLife is deteriorating rapidly, with sales plummeting 23% YoY due to persistent weakness at GNC and in the MRC brand. Aggressive debt paydown ($8.6 million since the acquisition) proves the model generates cash, but organic growth remains elusive.
🐂 Bull Case
The strategy to bypass wholesale and take Irwin direct-to-consumer on Amazon is working flawlessly. Amazon sales scaled from near-zero pre-acquisition to an $11M annual run rate in under a year.
Management has aggressively paid down $8.6M in debt over three quarters, driving $0.6M in annual interest savings. The balance sheet is de-risking rapidly despite operational headwinds.
🐻 Bear Case
Legacy FitLife revenue cratered 23% YoY. Wholesale dropped 31% due to specialty retail (GNC) struggles, and online dropped 19% as MRC continues to lose Amazon traffic. There is no clear bottom in sight.
Consolidated gross margin compressed to 37.0% from 42.8% a year ago. While Legacy margin remains somewhat stable, the structural shift toward the lower-margin Irwin portfolio fundamentally lowers the company's profitability ceiling.
⚖️ Verdict: ⚪
Neutral. The operational execution on the Irwin acquisition is highly commendable and cash flows are strong. However, investing here requires betting that Irwin's growth can outrun a severe, ongoing contraction in the core legacy business.
Key Themes
Legacy FitLife Revenue Collapse
Legacy FitLife revenue is decelerating sharply, down 23% YoY to $12.4M. The wholesale channel was decimated (-31%) largely due to GNC's struggles, while online (-19%) suffered from sustained MRC traffic declines. Though sequential sales were relatively flat vs Q1 2026, the YoY comparisons indicate severe brand deterioration.
Irwin Amazon Sales Accelerating
The pivot to Amazon for Irwin is the company's primary growth engine. Launched in October 2025, the brand hit ~$0.5M in December, ~$0.8M in March, and just under $1M in June. Online revenue now accounts for 24% of Irwin's total mix, up from ~4% at acquisition.
Supply Chain Overhaul to Boost Margins
Management is structurally improving Irwin's margin profile by extending product expiration dating from two years to three years. With 85% of formulas now approved for three-year dating, the company aims to eliminate the historical ~$2M in annual inventory obsolescence write-offs.
MusclePharm: Shrinking to Grow Profitably
MusclePharm revenue is down YoY, but management noted this is intentional. The company abandoned low-margin, price-sensitive international wholesale accounts. As a result, MusclePharm margins have expanded by 'several hundred basis points' sequentially, and its Amazon performance has inflected back to double-digit growth.
Amazon Algorithm Dependency
FitLife is heavily exposed to Amazon's opaque algorithm changes. To combat declining on-platform session counts, the company increased Q2 marketing spend by 16.4% sequentially, redirecting dollars toward off-Amazon channels (Google, Meta, TikTok) to force external traffic onto Amazon listings. This increases customer acquisition costs.
Other KPIs
Stable sequentially, but a severe deceleration from 42.8% in Q2 2025. The decline is entirely mix-driven due to the Irwin acquisition. Legacy FitLife actually saw sequential gross margin expansion for the third consecutive quarter (up to 41.7%), offering a glimmer of pricing power resilience.
Up 10% YoY. Adjusted EBITDA growth significantly lagged the 65% revenue growth, underscoring the margin dilution from Irwin. However, SG&A was reduced by 3.8% sequentially (a $0.8M annualized run-rate savings), showing management's focus on cost control.
Debt reduction is accelerating. The company paid off $3.7 million in the quarter ($1.5M term loan, $2.2M revolver). Total debt paydown since the Irwin transaction sits at $8.6 million, significantly lowering leverage and generating $0.6 million in annualized interest savings at the current 6.5% rate.
Guidance
Accelerating. Achieved by the end of Q2 2026. This metric shows the speed of execution, jumping from a $9.6M implied run rate in Q1 to $11M in Q2, entirely built from scratch post-acquisition.
Management aims to reinvigorate Irwin's historically stagnant pipeline, intentionally pivoting away from declining categories (weight loss, men's health) toward high-growth nutritional supplement segments.
Key Questions
Legacy Bottoming Process
Legacy FitLife wholesale revenues dropped 31% YoY. Have we reached the bottom of the GNC and specialty retail destocking cycle, or should investors expect another leg down in Q3?
Irwin Cannibalization
Irwin's online business is surging, but is it cannibalizing existing wholesale accounts? What metrics are you tracking to ensure Amazon sales are truly incremental rather than channel-shifting?
Marketing ROI
Marketing spend increased 16.4% sequentially to combat Amazon algorithm changes. At what point does the rising cost of off-platform customer acquisition begin to materially degrade online contribution margins?